These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3097675)

  • 21. The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate.
    Bachus KE; Hughes CL; Haney AF; Dodson WC
    Fertil Steril; 1990 Jul; 54(1):27-31. PubMed ID: 2113488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian stimulation during gonadotropin treatment after hCG administration monitored by ultrasound and serum estradiol and progesterone.
    Ylöstalo P; Siegberg R
    Int J Fertil; 1988; 33(4):259-64. PubMed ID: 2902041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
    Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful pregnancy in a woman with Kallmann's syndrome using human menopausal gonadotropin followed by low-dose human chorionic gonadotropin in the mid-to-late follicular phase.
    Yu HT; Lee CL; Huang HY; Soong YK
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):300-2. PubMed ID: 22795116
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy of ovulatory sterility and corpus luteum insufficiency with human menopausal and chorionic gonadotropins.
    Caspi E; Hirsch H
    Isr J Med Sci; 1971 Sep; 7(9):1040-5. PubMed ID: 5151269
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation.
    Venturini PL; Remorgida V; Anserini P; De Cecco L
    Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Control of follicle maturation by estrogen determination in the serum and urine during treatment with gonadotropins].
    Seifert B; Hassler MP; Helbing W
    Zentralbl Gynakol; 1983; 105(8):482-6. PubMed ID: 6408837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins.
    Charbonnel B; Krempf M; Blanchard P; Dano F; Delage C
    Fertil Steril; 1987 Jun; 47(6):920-4. PubMed ID: 2954858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of purified gonadotrophins for ovarian stimulation in IVF.
    Jones GS
    Clin Obstet Gynaecol; 1985 Dec; 12(4):775-84. PubMed ID: 3938687
    [No Abstract]   [Full Text] [Related]  

  • 32. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
    Aboulghar MA; Mansour RT; Serour GI
    Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of ovulation with menotropins in women with polycystic ovary syndrome.
    Kemmann E; Tavakoli F; Shelden RM; Jones JR
    Am J Obstet Gynecol; 1981 Sep; 141(1):58-64. PubMed ID: 6791502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome.
    Dunaif A
    Curr Ther Endocrinol Metab; 1994; 5():222-9. PubMed ID: 7704720
    [No Abstract]   [Full Text] [Related]  

  • 39. GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Gynecol Endocrinol; 1989 Dec; 3(4):309-15. PubMed ID: 2516706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current experience with a standardized method of human menopausal gonadotropin/human chorionic gonadotropin administration.
    Radwanska E; Hammond J; Hammond M; Smith P
    Fertil Steril; 1980 May; 33(5):510-3. PubMed ID: 6768598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.